- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 22, 2026 | 34.8M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 35M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 35.7M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $19.5M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $85.2M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $45.2M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $40.9M |
| Capex | Q1 2026 · Mar 31, 2026 | $55.5M |
| Capex | Q1 2026 · Mar 31, 2025 | $25.5M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $16.1M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$35.8M |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $2M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $500K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $48.2M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $34.2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.21B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.16B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $973.7M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $962.1M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.29B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.19B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.08B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.92B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.03B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.9B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.29B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.08B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.35 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | $3.63 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $3.37 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | $3.65 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $185.2M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $171.3M |
| Net Income | Q1 2026 · Mar 31, 2026 | $117.2M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $129.6M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $163.5M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $168M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $351.3M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $340.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $783.8M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $731.7M |
| Revenue | Q1 2026 · Mar 31, 2026 | $1.14B |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.07B |